To the best of our knowledge, this study is the first to demonstrate the existence of both FcεRI-αβγ
2 and FcεRI-αγ
2 receptor subtypes in the giant papillae of patients with chronic allergic conjunctivitis. FcεRI-β staining
(Figs. 1 2)showed a membranous staining pattern at the giant papillae. This staining pattern is consistent with our previous in vitro study using cultured human mast cells.
7 FcεRI-α staining of the same slide showed a broader expression at the conjunctiva than that of FcεRI-β
(Fig. 2C) , and all the FcεRI-α
+ cells were FcεRI-γ
+ (Fig. 2F) . These findings showed the existence of FcεRI-αβγ
2 mast cells and FcεRI-αγ
2 mast cells in the giant papillae. In our previous study, we quantified FcεRI-β protein expression in human mast cells using flow cytometry.
7 We found monophasic rather than biphasic FcεRI-β expression pattern in human mast cells,
7 and Western blotting showed that the sensitivity of the FcεRI-β antibody is approximately 100 pg in the recombinant FcεRI-β protein (Matsuda A, unpublished data, 2008). These results suggested that there are various levels of FcεRI-β expression in each mast cell, and we identified an area of the mast cell population that expresses the FcεRI-β protein past the threshold as FcεRI-β-positive cells. We could not deny the possibility that FcεRI-αβγ
2 and FcεRI-αγ
2 receptor subtypes could be coexpressed in one mast cell. Nevertheless, we could conclude that there were at least two types of mast cells dominated by FcεRI-αβγ
2 or by FcεRI-αγ
2 receptors. We further examined FcεRI-β expression in the conjunctivae of two nonatopic conjunctival diseases as controls. We selected patients with conjunctivochalasis because relatively large upper bulbar conjunctivae samples could be obtained at the time of surgery. We examined patients with SLK as controls for two reasons: because an increased number of mast cells has been reported in the SLK conjunctivae
24 and to avoid bias from the very low number of the mast cells in the conjunctivochalasis samples. In addition, we excluded allergic conjunctivitis by careful slit-lamp examinations in these cases. The increased number of FcεRI-β
+ cells and the higher ratio of FcεRI-β
+/FcεRI-α
+ cells number in giant papillae samples suggested the preferential expression of FcεRI-β protein in chronic allergic conjunctivitis.